Research peptide
Semax
Derived from the 4-7 fragment of adrenocorticotropic hormone (ACTH) and extended with a Pro-Gly-Pro tail for added stability, Semax is a synthetic heptapeptide widely documented in the nootropic literature. It is studied for upregulating brain-derived neurotrophic factor (BDNF) and modulating dopaminergic, serotonergic and cholinergic systems. Lyophilised powder offered in 10mg and 30mg vials, ≥99% purity by HPLC, Certificate of Analysis on request. Dispatched from the UK, for research use only. Research applications BDNF upregulation and neurotrophic-pathway modulation studies Cognition, memory-consolidation and learning research models Neuroprotection assays under hypoxia and oxidative stress Dopaminergic, serotonergic and cholinergic system modulation Comparative nootropic research against Selank and related CNS peptides Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 10mg · 30mg Certificate of Analysis: available on request
Size: 10mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- Semax receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
